Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NanoVibronix, Inc. - Common Stock (NQ: NAOV )

0.4800 -0.0430 (-8.22%)
Streaming Delayed Price Updated: 2:03 PM EST, Feb 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 446,505
Open 0.4940
Bid (Size) 0.4753 (5)
Ask (Size) 0.4894 (1)
Prev. Close 0.5230
Today's Range 0.4700 - 0.5060
52wk Range 0.3650 - 1.520
Shares Outstanding 3,752,354
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's pre-market session
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Performance

YTD
-22.58%
-22.58%
1 Month
-31.43%
-31.43%
3 Month
-15.64%
-15.64%
6 Month
-25.06%
-25.06%
1 Year
-49.94%
-49.94%

More News

Read More
What's going on in today's after hours session
Via Chartmill
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
NAOV Stock Earnings: NanoVibronix Reported Results for Q2 2024
Via InvestorPlace
NAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024
Via InvestorPlace
Which stocks are most active on Thursday?
Via Chartmill
Top stock movements in today's session.
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Provides Business Update
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Signs Letter of Intent with Potential New Distributor
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Issues Letter to Stockholders
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.